60,060 Shares in Aspen Aerogels, Inc. $ASPN Acquired by Savant Capital LLC

Savant Capital LLC purchased a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 60,060 shares of the construction company’s stock, valued at approximately $356,000.

Other large investors have also modified their holdings of the company. Gagnon Securities LLC acquired a new position in shares of Aspen Aerogels in the 2nd quarter valued at $11,243,000. AWM Investment Company Inc. grew its position in Aspen Aerogels by 102.6% during the 1st quarter. AWM Investment Company Inc. now owns 2,449,221 shares of the construction company’s stock worth $15,651,000 after purchasing an additional 1,240,535 shares during the last quarter. MetLife Investment Management LLC grew its position in Aspen Aerogels by 2,036.3% during the 1st quarter. MetLife Investment Management LLC now owns 764,423 shares of the construction company’s stock worth $4,885,000 after purchasing an additional 728,641 shares during the last quarter. Penn Capital Management Company LLC purchased a new stake in shares of Aspen Aerogels in the first quarter valued at about $4,107,000. Finally, Goldman Sachs Group Inc. boosted its stake in shares of Aspen Aerogels by 89.7% during the first quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock worth $8,143,000 after buying an additional 602,586 shares during the period. 97.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, CEO Donald R. Young sold 56,845 shares of the business’s stock in a transaction dated Thursday, November 13th. The shares were sold at an average price of $3.23, for a total transaction of $183,609.35. Following the sale, the chief executive officer owned 494,011 shares of the company’s stock, valued at approximately $1,595,655.53. The trade was a 10.32% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 4.30% of the company’s stock.

Aspen Aerogels Trading Down 0.2%

Shares of ASPN stock opened at $3.08 on Tuesday. The business’s fifty day moving average price is $6.90 and its 200 day moving average price is $6.69. The firm has a market capitalization of $254.14 million, a PE ratio of -0.81 and a beta of 2.85. The company has a debt-to-equity ratio of 0.34, a current ratio of 3.98 and a quick ratio of 3.31. Aspen Aerogels, Inc. has a 1-year low of $3.01 and a 1-year high of $15.38.

Aspen Aerogels (NYSE:ASPN) last released its earnings results on Thursday, November 6th. The construction company reported ($0.06) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The business had revenue of $73.02 million during the quarter, compared to analyst estimates of $73.42 million. During the same period last year, the business posted ($0.17) EPS. Aspen Aerogels’s revenue was down 37.8% compared to the same quarter last year. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. As a group, sell-side analysts forecast that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

ASPN has been the topic of several recent research reports. Zacks Research cut Aspen Aerogels from a “hold” rating to a “strong sell” rating in a research report on Monday, November 10th. Canaccord Genuity Group dropped their target price on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating on the stock in a report on Friday, November 7th. Barclays cut their price target on Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating for the company in a research note on Friday, November 7th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Aspen Aerogels in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, two have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $12.67.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.